EUROPHARMACEUTICALS
ActiveFrom the official registers: KBO 38 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The computed 12-month bankruptcy probability of EUROPHARMACEUTICALS is 2.1% (moderate). The 2025 annual accounts show negative equity (-€2,911) and a net result of -€19,213. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 18% of 13,716 sector peers (NACE 46, financial year 2025). The company has been active since 1984 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry.
Overview
Official details
KBO- Status
- Active since 29-03-1984 Normal situation
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460and 2 others
- Establishment unit
- 2.029.628.691 1180 Ukkel, since 23-07-1987
- Financial year end
- 31 December
- Peppol
- Reachable since 21-08-2025
Board and ownership
- GECZY Marie-Laurence PascaleDirector
- GÉCZY József MihályDirector
Financial position
- Bankruptcy probabilitywithin 12 months
- 2.1%
- Gross margin
- -€15,369
- ▼ 371%
- Loss
- €19,213
- ▲ 22.6%
- Equity
- -€2,911
- Total assets
- €54,573
- ▼ 18.1%
Score breakdownraises riskLoss of €19,213, the second in a row (financial year 2025)Negative equity -€2,911lowers riskSize: total assets €54,573Founded in 1984Show the evidence
Checked score
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 15% of them on solvency, 51% on liquidity, 6% on profitability and 4% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 77 days after the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (1)
Key points
Comparable companies
These companies have the same main activity as EUROPHARMACEUTICALS: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €21,700 and €111,000, founded between 1978 and 2000.
| Company | Total assets | Gross margin |
|---|---|---|
| EUROPHARMACEUTICALS Ukkel | €54,573 | -€15,369 |
| GLOBEX INTERNATIONAL Antwerpen | €92,829 | -€13,905 |
| STOMA INTERNATIONAL Schaarbeek | €65,737 | -€2,791 |
| BIOMEDECINE Vilvoorde | €27,357 | -€6,132 |
| Natural Care Herselt | €111,341 | -€6,600 |
| OFURO GROUP Zaventem | €48,053 | -€8,491 |
| FREMED Kortrijk | €21,724 | -€2,604 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 16-06-2026
- Annual accounts 2024filed on 08-09-2025
- Annual accounts 2023filed on 31-10-2024
- Annual accounts 2022filed on 21-11-2023
Acts in the Belgian Official Gazette
- Name · Resignations & appointmentsact of 02-04-2025
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about EUROPHARMACEUTICALS
- What is the company number of EUROPHARMACEUTICALS?
- The company number of EUROPHARMACEUTICALS is 0425.594.923. The VAT number is the same number with BE in front: BE 0425.594.923.
- Where is EUROPHARMACEUTICALS based?
- The registered office is at Wolvendaellaan 21, 1180 Ukkel.Company details
- What does EUROPHARMACEUTICALS do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of EUROPHARMACEUTICALS?
- The legal form of EUROPHARMACEUTICALS is Public limited company (NV).
- When was EUROPHARMACEUTICALS founded?
- EUROPHARMACEUTICALS was founded on 29-03-1984.
- Is EUROPHARMACEUTICALS still active?
- Yes, EUROPHARMACEUTICALS is an active enterprise in the KBO register.
- What is the turnover of EUROPHARMACEUTICALS?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is EUROPHARMACEUTICALS profitable?
- In financial year 2025, EUROPHARMACEUTICALS made a loss of €19,213.
- Where can I find the annual accounts of EUROPHARMACEUTICALS?
- EUROPHARMACEUTICALS filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
- When are the next annual accounts of EUROPHARMACEUTICALS due?
- EUROPHARMACEUTICALS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.